Source: Annual Congress 2002 - Asthma - Therapy and management -1
Disease area: Airway diseases

Abstract

Background : The socioeconomic problems in Brazil are important and the asthmatics have difficulties in assessing health provides as well as they did not have insurance for medicine Aim: To estimate direct and indirect costs with asthma attendance to help a better expenditure in asthma treatment. Design: A survey applied in asthmatic at emergency attendance Methods. A questionnaire was applied to obtain: symptoms score, medication intake, n[degree] ER visits and hospitalization as well as lost of work or school days and premature retirement because asthma over last 6 months. Results44 patients classified by GINA as mild= 17 (39%), moderate = 19(43%) and severe = 8(18%), and average months income US$ 380,20. Only 22,7% used daily inhaled anti-inflammatory medication. The following table demonstrates the mean costs/patients in USS stratified according to severity asthma

	Mild	Moderate	Severe
Medicines (US$)	7.28	62.68	180.72
ER visits(US$)	2.72	10.73	26.00
Hospitalization(US$)	-	-	34.00
Intensive care(US$)	-	-	23.85
Work absence(US$)	22.50	58.33	126.25
School absence (number of days)	7	32	15
Retirement (number of patients)	-	3	-

The impact of the cost of medication in monthly income were, 0,34% , 5,4% and 10% to mild ,moderate and severe asthma respectively .Conclusions: The medicines represent the main cost for the patients and could reduce the complience with the treatment.
Partially supported by FAPESP

Rating:

Share or cite this content

Citations should be made in the following way:
L. A. Santos, M. A. Oliveira, S. M. Faresin, A. Barbieri, A. L. G. Fernandes (São Paulo, Brazil). Health care costs associated with acute asthma: a economic analysis. Eur Respir J 2002; 20: Suppl. 38, 385

Member's Comments

No comment yet.

Related content which might interest you: Health care cost associated with acute and stable asthma: an economic analysis Source: Eur Respir J 2003; 22: Suppl. 45, 418s Year: 2003 Health care claims analysis to quantify the burden of moderate-to-severe asthma Source: Annual Congress 2012 - Looking at the cost effectiveness of asthma and COPD treatment by novel drugs and improved management Year: 2012 Health care utilization and costs of asthma and COPD in the Netherlands Source: Eur Respir J 2005; 26: Suppl. 49, 383s Year: 2005 Cost of health care associated with workplace exacerbation of asthma Source: Eur Respir J 2007; 30: Suppl. 51, 157s Year: 2007 Are acute asthma admissions preventable with improved patient education? Source: Annual Congress 2013 –Treatment and management of asthma in primary care Year: 2013 COPD admissions and inhaled medications: Escalating prescription costs but no evidence of effect. A national primary care study Source: Annual Congress 2013 –Quality of diagnosis and assessment in primary care Year: 2013 Predictive value of annual costs on 3-year mortality in COPD Source: International Congress 2015 – Patient health gains related to the economic effectiveness of disease management programmes Year: 2015 Long-term evaluation of seasonal out-of-pocket medical costs in patients with chronic respiratory disease based on a survey Source: Annual Congress 2013 –Respiratory nursing care: assessment, interventions and education Year: 2013 Health services utilisation by COPD patients in clinical stability and during an exacerbation Source: Eur Respir J 2003; 22: Suppl. 45, 217s Year: 2003 Cost and effectiveness of integrated care intervention on the patients with COPD Source: Annual Congress 2013 –The best posters in chronic care Year: 2013 Health care costs in COPD patients with severe respiratory failure: a prospective analysis Source: Annual Congress 2009 - Organisation of care for individuals with chronic respiratory disease Year: 2009 COPD readmissions in an urban environment: Health service factors Source: International Congress 2015 – Diagnosing and management of COPD in primary care Year: 2015 An outreaching model of tertiary difficult asthma care reduces adverse asthma outcomes and healthcare utilisation costs Source: Eur Respir J 2016; 47:1857-1860 Year: 2016 Asthma severity and medical resource utilisation Source: Eur Respir J 2004; 23: 723-729 Year: 2004 Impact of nurse-led outpatient management of children with asthma on healthcare resource utilisation and costs Source: Eur Respir J 2004; 23: 304-309 Year: 2004 External validation of exacerbation and mortality outcomes of health economic decision models for COPD Source: International Congress 2016 – Prevalence, prognosis, and risk factors of COPD Year: 2016 Evaluating a developmental care for the family rearing children with chronic asthma on the asthma-related quality of life and lung function Source: International Congress 2016 – The wide spectrum of respiratory nursing research and practice: across all ages and diseases Year: 2016 Health outcomes assessment and economic evaluation in COPD: challenges and opportunities Source: Eur Respir J 2003; 21: 1S-3S Year: 2003 The clinical and economic impact of the combined interventions of telehealth, specialist respiratory nursing care and health coaching interventions for COPD admissions within an urban setting Source: International Congress 2016 – Targeting care, pulmonary rehabilitation, management, and self-management of COPD exacerbations in primary care Year: 2016 The relationship between social deprivation and hospital admissions with asthma Source: Annual Congress 2013 –Treatment and adherence to treatment of respiratory disease Year: 2013